Skip to main content

Table 4 Characteristics of patients who survived greater than 12 months

From: Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma

Patient

Stage at diagnosisa

Status of primary tumour

Site of metastases

PFS in the liver (months)

PFS (months)

Survival (months)

Site of first disease progression

Patient 1

Tx

Primary in situ

Liver only

6.5

6.5

16.2

Liver

Patient 2

T2

Prior resection

Liver only

17.7

16.3

17.7

Pleural effusion

Patient 3

T3

Prior resection

Liver and lymph nodes

8.5

8.5

19.5

Liver

  1. aAccording to United Network for Organ Sharing staging criteria